does medicare cover glp 1 meds Tirzepatide GLP-1 medication may be most effective for weight loss Tirzepatide vs. Semaglutide: Which GLP-1

a Evaluable patients

participants reported a 119 percent improvement in well-being after three months and a 72 percent reduction in self-reported cravings after eight months

Important Note : If you have heart failure, chronic kidney disease, or liver disease, follow your healthcare provider's specific guidance on fluid intake, as these conditions may require fluid restriction rather than increased consumption

These costsaving results have implications for patients, physicians, insurers, and governments

In the STEP trials, participants taking semaglutide lost significantly more weight than those on placebo, with weight loss continuing for the full duration of treatment

The most significant improvements are typically observed in the first 3-6 months, with appetite suppression occurring within the first few weeks of treatment